Aorto-Iliac Occlusive Disease Treatment Market Size Worth USD 3.56 Billion by 2034 | CAGR: 5.3%

The aorto-iliac occlusive disease treatment market size is expected to reach USD 3.56 billion by 2034, according to a new study by Polaris Market Research. The report “Aorto-Iliac Occlusive Disease Treatment Market Size, Share, & Industry Analysis Report: By Device Type (Endovascular Devices and Surgical Devices), By Procedure, By End Use, and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The aorto-iliac occlusive disease treatment market addresses the medical and surgical management of arterial blockages occurring in the aorta and iliac arteries, typically caused by atherosclerosis. The increasing prevalence of chronic conditions such as diabetes, hypertension, and obesity has intensified clinical demand for both endovascular and open surgical interventions. Endovascular procedures, particularly angioplasty and stenting, have become the preferred therapeutic approach due to their lower complication rates, reduced hospital stays, and improved patient outcomes.

Market growth is supported by advancements in device technologies, including drug-eluting stents, bioresorbable scaffolds, and image-guided navigation systems, which enhance precision and long-term efficacy. Industry players are focusing on hybrid revascularization techniques to treat complex lesions and multilevel occlusions, creating new avenues for treatment optimization. There is also a rising trend toward outpatient vascular care centers, where minimally invasive interventions are being performed in high volumes. Increasing emphasis on early detection, risk stratification, and lifestyle modification programs has elevated the importance of integrated care models.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:https://www.polarismarketresearch.com/industry-analysis/aorto-iliac-occlusive-disease-treatment-market/request-for-sample

The convergence of diagnostic imaging, artificial intelligence, and vascular robotics is gradually transforming the treatment paradigm, paving the way for more personalized, data-driven interventions. Investments in clinical trials and post-market surveillance studies continue to inform device safety, durability, and performance metrics. Opportunities lie in expanding access to next-generation therapies in underserved populations and refining treatment algorithms to improve outcomes in high-risk patients. The market is steadily evolving into a more technologically enabled, outcome-focused ecosystem that emphasizes procedural efficiency, long-term patency, and patient quality of life.

Top of FormAorto-Iliac Occlusive Disease Treatment Market Report Highlights

• By device type, in 2024, the endovascular devices segment captured the largest share, primarily driven by the increasing preference for minimally invasive surgery in managing aorto-iliac occlusive disease.
• Based on end use, in 2024, the hospitals segment accounted for the largest share, fueled by their capacity to manage high-risk cases requiring multidisciplinary teams, advanced imaging, and surgical backup.
• In 2024, the North America aorto-iliac occlusive disease treatment market accounted for the largest share due to the widespread use of advanced endovascular procedures, strong reimbursement frameworks, and early diagnosis practices.
• The Asia Pacific aorto-iliac occlusive disease treatment market is projected to register the highest CAGR during the forecast period due to rising healthcare access, expanding medical infrastructure, and increasing awareness of vascular conditions.
• A few global key players include Abbott; BD.; Bentley InnoMed; Biotronik SE & Co KG; Boston Scientific Corporation; Cook; Getinge AB; iVascular; Medtronic; Scitech Medical; Terumo Corporation; W. L. Gore & Associates, Inc.; and ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Polaris Market Research has segmented the aorto-iliac occlusive disease treatment market on the basis of device type, procedure, end use, and region:

By Device Type Outlook (Revenue, USD Billion, 2020–2034)

• Endovascular Devices
  • Balloon Angioplasty Devices
  • Atherectomy Systems
  • Stents
• Surgical Devices

By Procedure Outlook (Revenue, USD Billion, 2020–2034)

• Endovascular Procedures
• Hybrid Procedures
• Open Surgical Procedures

By End Use Outlook (Revenue, USD Billion, 2020–2034)

• Hospitals
• Outpatient Facilities
• Others

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America

• US
• Canada

• Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe

• Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Vietnam
• Australia
• Rest of Asia Pacific

• Latin America

• Argentina
• Brazil
• Mexico
• Rest of Latin America

• Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa